H.R. 354 — North American Prescription Price Equity Act of 2003

Summary

North American Prescription Price Equity Act of 2003 - Amends the Internal Revenue Code to allow drug manufacturers a limited tax credit if they certify that the wholesale price of a drug in the United States market is not greater than its wholesale price in the Canadian or Mexican market.

Full Text

Legislative Actions

2003-01-27
Introduced in House
2003-01-27
Introduced in House
2003-01-27
Referred to the House Committee on Ways and Means.

North American Prescription Price Equity Act of 2003

Sponsors

Subjects

Summary

Full Text

Legislative Actions

Ask about this bill